I
Century Therapeutics D
D
IPSC
1.42000
USD
0.09
(6.77%)
مفتوح الان
حجم التداول
65
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
112,672,228
العنوان: Century Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.